NCT01180556
Completed
Not Applicable
The Effect of Probiotics in Childhood Abdominal Pain
ConditionsAbdominal Pain
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Abdominal Pain
- Sponsor
- Soroka University Medical Center
- Enrollment
- 101
- Locations
- 1
- Primary Endpoint
- Frequency and intensity of abdominal pain
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The purpose of this study is to assess the effect of probiotics in childhood recurrent abdominal pain. Patients will be randomly assigned to receive L. reuteri or placebo for 4 weeks with a follow up phase of additional 4 weeks.
Detailed Description
Prospective randomized double-blind placebo-controlled trial.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Healthy children
Exclusion Criteria
- •Any chronic or organic illness
Outcomes
Primary Outcomes
Frequency and intensity of abdominal pain
Time Frame: Eight weeks
Number of pain episodes and pain intensity based on a visual scale
Secondary Outcomes
- School absenteeism(Eight weeks)
- Other gastrointestinal symptoms(Eight weeks)
- Adverse effects related to treatment(Eight weeks)
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Phase 4
The Effects of Probiotics, Lactobacillus GG, in the Treatment of Abdominal Pain in Children With Functional Abdominal Pain DisordersFunctional Abdominal Pain SyndromeNCT06310733Prince of Songkla University54
Completed
Not Applicable
Efficacy of a Probiotic Product in Children With Antibiotic-associated Gastrointestinal DisordersAntibiotic-associated DiarrheaNCT02722993Probi AB117
Completed
Phase 1
Probiotics for Infectious Diarrhea in Children in South IndiaInfectious GastroenteritisNCT01130792Christian Medical College, Vellore, India124
Terminated
Phase 2
Benefit and Tolerability of a Probiotic Product in Infants With Abdominal DiscomfortAbdominal DiscomfortNCT01893814Probi AB5
Completed
Phase 3
Probiotics and Infections in Children Attending Day Care CentresRespiratory Tract InfectionsGastrointestinal DiseasesNCT01014676Valio Ltd